Advanced Protein Technologies Corp.
13Patents
10Active
13Granted
58Portfolio score
Filing activity: Feb 12, 1997 → Nov 22, 2023 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6005073A | Process for isolating a protein composition from a muscle source and protein composition | Human Necessities | 35 | Expired |
| US6451975B1 | Protein composition and process for isolating a protein composition from a muscle source | Chemistry; Metallurgy | 27 | Expired |
| US7473764B2 | Protein composition obtained from a muscle source | Chemistry; Metallurgy | 14 | Active |
| US7771970B2 | Process for preparation of polypeptides of interest from fusion polypeptides | Chemistry; Metallurgy | 2 | Expired |
| US12274708B2 | Composition for ameliorating or treating dementia containing 2′-fucosyllactose | Human Necessities | 0 | Active |
| US10876122B2 | Method of producing 2′-fucosyllactose using recombinant Corynebacterium glutamicum | Chemistry; Metallurgy | 0 | Active |
| US11214808B2 | Method of producing 2′-fucosyllactose using fucosyltransferase derived from Pseudopedobacter saltans | Chemistry; Metallurgy | 0 | Active |
| US12133858B2 | Composition for promoting hair growth and improving, preventing, or treating hair loss containing 2′-fucosyllactose as an active ingredient | Human Necessities | 0 | Active |
| US11753665B2 | Method for improving productivity of 2′-fucosyllactose through enzymatic treatment | Chemistry; Metallurgy | 0 | Active |
| US12168020B2 | Method for ameliorating, preventing or treating muscular atrophy or sarcopenia by administering composition comprising 2′-fucosyllactose as active ingredient | Human Necessities | 0 | Active |
| US11512318B2 | Method for producing 3-fucosyllactose using Corynebacterium glutamicum | Chemistry; Metallurgy | 0 | Active |
| US11980632B2 | Antiviral composition containing fucosyllactose as active ingredient | Human Necessities | 0 | Active |
| US11819510B2 | Food composition for ameliorating cerebrovascular diseases containing 2′- fucosyllactose and pharmaceutical composition for preventing or treating cerebrovascular diseases containing 2′-fucosyllactose | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.